Table 4.
The association of biochemical and clinical parameters with prevalence of prediabetes based on the adjusted analyses—logistic regression model among participants: The Hoveyzeh Cohort Study
| Variables | Male | Female | Total | |||
|---|---|---|---|---|---|---|
| ▀Adjusted OR (95%CI) | P | ▀Adjusted OR (95%CI) | p | ▀Adjusted OR (95%CI) | P | |
| Triglyceride (mg/dl) (≤ 150 mg/dl) | ||||||
| 150-199 mg/dl | 1.06 (0.85,1.33) | 0.6 | 1.32(1.11,1.58) | 0.002 | 1.32(1.16,1.51) | < 0.001 |
| ≥ 200 mg/dl | 1.36 (1.11,1.67) | 0.03 | 1.73(1.44,2.07) | < 0.001 | 1.64(1.44,1.86) | < 0.001 |
| Cholesterol (≤ 200 mg/dl) | ||||||
| 200–239 mg/dl | 1.18(1.01,1.44) | < 0.001 | 1.18 (1.01,1.38) | 0.042 | 1.33 (1.18,1.49) | < 0.001 |
| ≥ 240 mg/dl | 2 (1.5, 2.68) | < 0.001 | 1.53 (1.22,1.91) | < 0.001 | 2.04 (1.72,2.42) | < 0.001 |
| HDL-C (Normal)* | ||||||
| Abnormal* | 0.91 (0.75,1.105) | 0.35 | 1.035 (0.9,1.19) | 0.63 | 1.04(0.93,1.16) | 0.47 |
| Systolic Blood Pressure (≤ 140 mmHg) | ||||||
| ≥ 140 mmHg | 1.48 (1.11,1.98) | 0.008 | 1.39 (1.07,1.82) | 0.014 | 1.95(1.62,2.35) | < 0.001 |
| Diastolic Blood Pressure (≤ 90 mmHg) | ||||||
| ≥ 90 mmHg | 1.14 (0.84,1.55) | 0.38 | 1.31 (0.98,1.76) | 0.011 | 1.54(1.26,1.89) | < 0.001 |
| GOT | 1.016 (1.007,1.026) | 0.001 | 1.012 (1.003,1.02) | 0.005 | 1.013 (1.007,1.019) | 0.001 |
| GPT | 1.009 (1.005,1.014) | < 0.001 | 1.012 (1.006,1.017) | < 0.001 | 1.01 (1.006,1.013) | < 0.001 |
HDL-C High-density Lipoprotein Cholesterol, GOT Glutamic Oxaloacetic transaminase, GPT Glutamic pyruvic transaminase
*For male: HDL-C < 40 mg/dl, for women < 50 mg/dl
Normal HDL-C is defined as HDL-C ≥ 40 (in men) and ≥ 50 mg/dl (in women)
OR Odds ratio, CI Confidence Interval
P-value < 0.05 was considered significant
▀Adjusted for all variables in Table 3 (age real, Marital status, wealth scores, smoking cigarette, Alcohol drinker, history of CI, MI, and stroke, Body Mass Index, PA, and daily energy intake)